🇺🇸 FDA
Patent

US 6977244

Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides

expired A61KA61K38/00A61K9/127

Quick answer

US patent 6977244 (Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides) held by The Board of Regents of the University of Texas System expires Mon Dec 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 20 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
43
CPC classes
A61K, A61K38/00, A61K9/127, A61P, A61P35/00